Funded by the NIH HEAL Initiative®
This study will examine whether 1) in hospitals with addiction medicine consultation services, hospital-initiated extended release buprenorphine (XR-BUP), compared to other OUD medications, results in increased OUD treatment engagement following hospital discharge; and 2) training hospitals without such consultation services on best practices for initiating OUD medication using consultation service hubs improves medication uptake in hospitals and following discharge.
Gavin Bart, M.D., Ph.D., FACP, FASAM
701 Park Avenue G5
Minneapolis, MN 55415
Richard Saitz, MD, MPH, FACP, DFASAM
801 Massachusetts Ave., 4th Floor
Boston, MA 02118